Differential uptake of nanoparticles and microparticles by pulmonary APC subsets induces discrete immunological imprints

Journal of Immunology

Volumn 191, Issue 10, 2013, Pages 5278-5290

  Hardy, Charles L ^a,b   Lemasurier, Jeanne S ^a,b   Mohamud, Rohimah ^a,b   Yao, Jun ^a,b   Xiang, Sue D ^a,b   Rolland, Jennifer M ^a,b   O'Hehir, Robyn E ^a,b   Plebanski, Magdalena ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b Cooperative Research Centre for Asthma and Airways ^*  (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CD103 ANTIGEN; CD11B ANTIGEN; CYTOKINE; NANOPARTICLE; POLYSTYRENE; PS500G; PS50G; UNCLASSIFIED DRUG; CHEMOKINE; MICROSPHERE; POLYSTYRENE DERIVATIVE;

ADAPTIVE IMMUNITY; ALLERGIC AIRWAY INFLAMMATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; CELL MATURATION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; IMMUNE RESPONSE; LUNG ALVEOLUS MACROPHAGE; LYMPH NODE; LYMPHATIC DRAINAGE; MEDIATOR; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; ANIMAL; ANTIGEN PRESENTATION; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL MOTION; CHEMICALLY INDUCED; CYTOLOGY; IMMUNOLOGY; INFLAMMATION; LUNG; MACROPHAGE; METABOLISM;

ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD11B; CELL MOVEMENT; CHEMOKINES; CYTOKINES; DENDRITIC CELLS; FEMALE; INFLAMMATION; LUNG; LYMPH NODES; MACROPHAGES; MICE; MICE, INBRED BALB C; MICROSPHERES; NANOPARTICLES; PARTICLE SIZE; POLYSTYRENES;

EID: 84887413652     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1203131     Document Type: Article

References (58)

1. Brunekreef, B., and S. T. Holgate. 2002. Air pollution and health. Lancet 360:1233-1242.
2. Peters, A., H. E. Wichmann, T. Tuch, J. Heinrich, and J. Heyder. 1997. Respiratory effects are associated with the number of ultrafine particles. Am. J. Respir. Crit. Care Med. 155:1376-1383.
3. Penttinen, P., K. L. Timonen, P. Tiittanen, A. Mirme, J. Ruuskanen, and J. Pekkanen. 2001. Ultrafine particles in urban air and respiratory health among adult asthmatics. Eur. Respir. J. 17:428-435.
4. Von Klot, S., G. Wölke, T. Tuch, J. Heinrich, D. W. Dockery, J. Schwartz, W. G. Kreyling, H. E. Wichmann, and A. Peters. 2002. Increased asthma medication use in association with ambient fine and ultrafine particles. Eur. Respir. J. 20:691-702.
5. Li, N., M. Wang, L. A. Bramble, D. A. Schmitz, J. J. Schauer, C. Sioutas, J. R. Harkema, and A. E. Nel. 2009. The adjuvant effect of ambient particulate matter is closely reflected by the particulate oxidant potential. Environ. Health Perspect. 117:1116-1123.
6. Alessandrini, F., H. Schulz, S. Takenaka, B. Lentner, E. Karg, H. Behrendt, and T. Jakob. 2006. Effects of ultrafine carbon particle inhalation on allergic inflammation of the lung. J. Allergy Clin. Immunol. 117:824-830.
7. De Haar, C., I. Hassing, M. Bol, R. Bleumink, and R. Pieters. 2006. Ultrafine but not fine particulate matter causes airway inflammation and allergic airway sensitization to co-administered antigen in mice. Clin. Exp. Allergy 36:1469-1479.
8. Larsen, S. T., M. Roursgaard, K. A. Jensen, and G. D. Nielsen. 2010. Nano titanium dioxide particles promote allergic sensitization and lung inflammation in mice. Basic Clin. Pharmacol. Toxicol. 106:114-117.
9. Inoue, K., E. Koike, R. Yanagisawa, S. Hirano, M. Nishikawa, and H. Takano. 2009. Effects of multi-walled carbon nanotubes on a murine allergic airway inflammation model. Toxicol. Appl. Pharmacol. 237:306-316.
10. Inoue, K., R. Yanagisawa, E. Koike, M. Nishikawa, and H. Takano. 2010. Repeated pulmonary exposure to single-walled carbon nanotubes exacerbates allergic inflammation of the airway: Possible role of oxidative stress. Free Radic. Biol. Med. 48:924-934.
11. Hardy, C. L., J. S. Le Masurier, G. T. Belz, K. Scalzo-Inguanti, J. Yao, S. D. Xiang, P. Kanellakis, A. Bobik, D. H. Strickland, J. M. Rolland, et al. 2012. Inert 50-nm polystyrene nanoparticles that modify pulmonary dendritic cell function and inhibit allergic airway inflammation. J. Immunol. 188:1431-1441.
12. Lambrecht, B. N., and H. Hammad. 2003. Taking our breath away: dendritic cells in the pathogenesis of asthma. Nat. Rev. Immunol. 3:994-1003.
13. Vermaelen, K., and R. Pauwels. 2005. Pulmonary dendritic cells. Am. J. Respir. Crit. Care Med. 172:530-551.
14. Thepen, T., K. Hoeben, J. Brevé, and G. Kraal. 1992. Alveolar macrophages down-regulate local pulmonary immune responses against intratracheally administered T-cell-dependent, but not T-cell-independent antigens. Immunology 76:60-64.
15. Thepen, T., C. McMenamin, B. Girn, G. Kraal, and P. G. Holt. 1992. Regulation of IgE production in pre-sensitized animals: in vivo elimination of alveolar macrophages preferentially increases IgE responses to inhaled allergen. Clin. Exp. Allergy 22:1107-1114.
16. Bedoret, D., H. Wallemacq, T. Marichal, C. Desmet, F. Quesada Calvo, E. Henry, R. Closset, B. Dewals, C. Thielen, P. Gustin, et al. 2009. Lung interstitial macrophages alter dendritic cell functions to prevent airway allergy in mice. J. Clin. Invest. 119:3723-3738.
17. Fifis, T., A. Gamvrellis, B. Crimeen-Irwin, G. A. Pietersz, J. Li, P. L. Mottram, I. F. McKenzie, and M. Plebanski. 2004. Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors. J. Immunol. 173:3148-3154.
18. Byersdorfer, C. A., and D. D. Chaplin. 2001. Visualization of early APC/T cell interactions in the mouse lung following intranasal challenge. J. Immunol. 167:6756-6764.
19. Bezemer, G. F., S. M. Bauer, G. Oberdörster, P. N. Breysse, R. H. Pieters, S. N. Georas, and M. A. Williams. 2011. Activation of pulmonary dendritic cells and Th2-type inflammatory responses on instillation of engineered, environmental diesel emission source or ambient air pollutant particles in vivo. J. Innate Immun. 3:150-166.
20. De Haar, C., M. Kool, I. Hassing, M. Bol, B. N. Lambrecht, and R. Pieters. 2008. Lung dendritic cells are stimulated by ultrafine particles and play a key role in particle adjuvant activity. J. Allergy Clin. Immunol. 121:1246-1254.
21. Nel, A. 2005. Atmosphere. Air pollution-related illness: effects of particles. Science 308:804-806.
22. Hardy, C. L., L. Kenins, A. C. Drew, J. M. Rolland, and R. E. O'Hehir. 2003. Characterization of a mouse model of allergy to a major occupational latex glove allergen Hev b 5. Am. J. Respir. Crit. Care Med. 167:1393-1399.
23. Kaewamatawong, T., N. Kawamura, M. Okajima, M. Sawada, T. Morita, and A. Shimada. 2005. Acute pulmonary toxicity caused by exposure to colloidal silica: particle size dependent pathological changes in mice. Toxicol. Pathol. 33:743-749.
24. Renwick, L. C., D. Brown, A. Clouter, and K. Donaldson. 2004. Increased inflammation and altered macrophage chemotactic responses caused by two ultrafine particle types. Occup. Environ. Med. 61:442-447.
25. Hardy, C. L., A. E. O'Connor, J. Yao, K. Sebire, D. M. De Kretser, J. M. Rolland, G. P. Anderson, D. J. Phillips, and R. E. O'Hehir. 2006. Follistatin is a candidate endogenous negative regulator of activin A in experimental allergic asthma. Clin. Exp. Allergy 36:941-950.
26. Lambrecht, B. N., and H. Hammad. 2012. Lung dendritic cells in respiratory viral infection and asthma: from protection to immunopathology. Annu. Rev. Immunol. 30:243-270.
27. Vermaelen, K. Y., I. Carro-Muino, B. N. Lambrecht, and R. A. Pauwels. 2001. Specific migratory dendritic cells rapidly transport antigen from the airways to the thoracic lymph nodes. J. Exp. Med. 193:51-60.
28. Plantinga, M., M. Guilliams, M. Vanheerswynghels, K. Deswarte, F. Branco-Madeira, W. Toussaint, L. Vanhoutte, K. Neyt, N. Killeen, B. Malissen, et al. 2013. Conventional and monocyte-derived CD11b (+) dendritic cells initiate and maintain T helper 2 cell-mediated immunity to house dust mite allergen. Immunity 38:322-335.
29. Kirby, A. C., M. C. Coles, and P. M. Kaye. 2009. Alveolar macrophages transport pathogens to lung draining lymph nodes. J. Immunol. 183:1983-1989.
30. Vermaelen, K., and R. Pauwels. 2003. Accelerated airway dendritic cell maturation, trafficking, and elimination in a mouse model of asthma. Am. J. Respir. Cell Mol. Biol. 29:405-409.
31. Von Garnier, C., L. Filgueira, M. Wikstrom, M. Smith, J. A. Thomas, D. H. Strickland, P. G. Holt, and P. A. Stumbles. 2005. Anatomical location determines the distribution and function of dendritic cells and other APCs in the respiratory tract. J. Immunol. 175:1609-1618.
32. Jakubzick, C., J. Helft, T. J. Kaplan, and G. J. Randolph. 2008. Optimization of methods to study pulmonary dendritic cell migration reveals distinct capacities of DC subsets to acquire soluble versus particulate antigen. J. Immunol. Methods 337:121-131.
33. Gretz, J. E., C. C. Norbury, A. O. Anderson, A. E. Proudfoot, and S. Shaw. 2000. Lymph-borne chemokines and other low molecular weight molecules reach high endothelial venules via specialized conduits while a functional barrier limits access to the lymphocyte microenvironments in lymph node cortex. J. Exp. Med. 192:1425-1440.
34. Sixt, M., N. Kanazawa, M. Selg, T. Samson, G. Roos, D. P. Reinhardt, R. Pabst, M. B. Lutz, and L. Sorokin. 2005. The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node. Immunity 22:19-29.
35. Wikstrom, M. E., E. Batanero, M. Smith, J. A. Thomas, C. Von Garnier, P. G. Holt, and P. A. Stumbles. 2006. Influence of mucosal adjuvants on antigen passage and CD4+ T cell activation during the primary response to airborne allergen. J. Immunol. 177:913-924.
36. Foged, C., B. Brodin, S. Frokjaer, and A. Sundblad. 2005. Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model. Int. J. Pharm. 298:315-322.
37. Reddy, S. T., A. J. Van Der Vlies, E. Simeoni, V. Angeli, G. J. Randolph, C. P. O'Neil, L. K. Lee, M. A. Swartz, and J. A. Hubbell. 2007. Exploiting lymphatic transport and complement activation in nanoparticle vaccines. Nat. Biotechnol. 25:1159-1164.
38. Geiser, M. 2010. Update on macrophage clearance of inhaled micro- and nanoparticles. J Aerosol Med Pulm Drug Deliv 23:207-217.
39. Takenaka, S., E. Karg, W. G. Kreyling, B. Lentner, W. Möller, M. Behnke-Semmler, L. Jennen, A. Walch, B. Michalke, P. Schramel, et al. 2006. Distribution pattern of inhaled ultrafine gold particles in the rat lung. Inhal. Toxicol. 18:733-740.
40. Semmler-Behnke, M., S. Takenaka, S. Fertsch, A. Wenk, J. Seitz, P. Mayer, G. Oberdörster, and W. G. Kreyling. 2007. Efficient elimination of inhaled nanoparticles from the alveolar region: evidence for interstitial uptake and subsequent reentrainment onto airways epithelium. Environ. Health Perspect. 115:728-733.
41. Geiser, M., M. Casaulta, B. Kupferschmid, H. Schulz, M. Semmler-Behnke, and W. Kreyling. 2008. The role of macrophages in the clearance of inhaled ultrafine titanium dioxide particles. Am. J. Respir. Cell Mol. Biol. 38:371-376.
42. Nakano, H., M. E. Free, G. S. Whitehead, S. Maruoka, R. H. Wilson, K. Nakano, and D. N. Cook. 2012. Pulmonary CD103 (+) dendritic cells prime Th2 responses to inhaled allergens. Mucosal Immunol. 5:53-65.
43. Persson, E. K., H. Uronen-Hansson, M. Semmrich, A. Rivollier, K. Hägerbrand, J. Marsal, S. Gudjonsson, U. Håkansson, B. Reizis, K. Kotarsky, and W. W. Agace. 2013. IRF4 transcription-factor-dependent CD103 (+) CD11b (+) dendritic cells drive mucosal T helper 17 cell differentiation. Immunity 38:958-969.
44. Del Rio, M. L., J. I. Rodriguez-Barbosa, E. Kremmer, and R. Förster. 2007. CD103- and CD103+ bronchial lymph node dendritic cells are specialized in presenting and cross-presenting innocuous antigen to CD4+ and CD8+ T cells. J. Immunol. 178:6861-6866.
45. Raymond, M., M. Rubio, G. Fortin, K. H. Shalaby, H. Hammad, B. N. Lambrecht, and M. Sarfati. 2009. Selective control of SIRP-alpha-positive airway dendritic cell trafficking through CD47 is critical for the development of T (H) 2-mediated allergic inflammation. J. Allergy Clin. Immunol. 124:1333-1342.e1331.
46. Belz, G. T., S. Bedoui, F. Kupresanin, F. R. Carbone, and W. R. Heath. 2007. Minimal activation of memory CD8+ T cell by tissue-derived dendritic cells favors the stimulation of naive CD8+ T cells. Nat. Immunol. 8:1060-1066.
47. Desch, A. N., G. J. Randolph, K. Murphy, E. L. Gautier, R. M. Kedl, M. H. Lahoud, I. Caminschi, K. Shortman, P. M. Henson, and C. V. Jakubzick. 2011. CD103+ pulmonary dendritic cells preferentially acquire and present apoptotic cell-associated antigen. J. Exp. Med. 208:1789-1797.
48. Manolova, V., A. Flace, M. Bauer, K. Schwarz, P. Saudan, and M. F. Bachmann. 2008. Nanoparticles target distinct dendritic cell populations according to their size. Eur. J. Immunol. 38:1404-1413.
49. Jakubzick, C., M. Bogunovic, A. J. Bonito, E. L. Kuan, M. Merad, and G. J. Randolph. 2008. Lymph-migrating, tissue-derived dendritic cells are minor constituents within steady-state lymph nodes. J. Exp. Med. 205:2839-2850.
50. Robays, L. J., T. Maes, S. Lebecque, S. A. Lira, W. A. Kuziel, G. G. Brusselle, G. F. Joos, and K. V. Vermaelen. 2007. Chemokine receptor CCR2 but not CCR5 or CCR6 mediates the increase in pulmonary dendritic cells during allergic airway inflammation. J. Immunol. 178:5305-5311.
51. Hammad, H., and B. N. Lambrecht. 2008. Dendritic cells and epithelial cells: linking innate and adaptive immunity in asthma. Nat. Rev. Immunol. 8:193-204.
52. Walzl, G., S. Tafuro, P. Moss, P. J. Openshaw, and T. Hussell. 2000. Influenza virus lung infection protects from respiratory syncytial virus-induced immunopathology. J. Exp. Med. 192:1317-1326.
53. Williams, A. E., L. Edwards, I. R. Humphreys, R. Snelgrove, A. Rae, R. Rappuoli, and T. Hussell. 2004. Innate imprinting by the modified heat-labile toxin of Escherichia coli (LTK63) provides generic protection against lung infectious disease. J. Immunol. 173:7435-7443.
54. Braun-Fahrländer, C., J. Riedler, U. Herz, W. Eder, M. Waser, L. Grize, S. Maisch, D. Carr, F. Gerlach, A. Bufe, et al; Allergy and Endotoxin Study Team. 2002. Environmental exposure to endotoxin and its relation to asthma in school-age children. N. Engl. J. Med. 347:869-877.
55. Eisenbarth, S. C., D. A. Piggott, J. W. Huleatt, I. Visintin, C. A. Herrick, and K. Bottomly. 2002. Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J. Exp. Med. 196:1645-1651.
56. Arora, M., S. L. Poe, T. B. Oriss, N. Krishnamoorthy, M. Yarlagadda, S. E. Wenzel, T. R. Billiar, A. Ray, and P. Ray. 2010. TLR4/MyD88-induced CD11b+Gr-1 int F4/80+ non-migratory myeloid cells suppress Th2 effector function in the lung. Mucosal Immunol. 3:578-593.
57. Kuipers, H., D. Hijdra, V. C. De Vries, H. Hammad, J. B. Prins, A. J. Coyle, H. C. Hoogsteden, and B. N. Lambrecht. 2003. Lipopolysaccharide-induced suppression of airway Th2 responses does not require IL-12 production by dendritic cells. J. Immunol. 171:3645-3654.
58. Matsushita, H., S. Ohta, H. Shiraishi, S. Suzuki, K. Arima, S. Toda, H. Tanaka, H. Nagai, M. Kimoto, A. Inokuchi, and K. Izuhara. 2010. Endotoxin tolerance attenuates airway allergic inflammation in model mice by suppression of the T-cell stimulatory effect of dendritic cells. Int. Immunol. 22:739-747.